Evaluating the risk of recurrence in neovascular age-related macular degeneration using OCT-angiography at the time of treatment exit. [PDF]
Jaggi D +5 more
europepmc +1 more source
Evolution of Anti-Vascular Endothelial Growth Factor Clinical Trial Design for Treating Neovascular Age-Related Macular Degeneration. [PDF]
Klufas MA +3 more
europepmc +1 more source
Integrating genetics, age and imaging to predict treatment outcomes in neovascular age-related macular degeneration: a proof-of-concept study. [PDF]
Moghul I +15 more
europepmc +1 more source
SPECTRUM: early clinical experience from the first global real-world study of aflibercept 8 mg in patients with neovascular age-related macular degeneration. [PDF]
Bailey C +11 more
europepmc +1 more source
Cross-Sectional Survey of Real-World Physician Prescribing Practices for Anti-VEGF Agents in the Treatment of Neovascular Age-Related Macular Degeneration and Associated Patient Burden in the United States. [PDF]
Gulati S +5 more
europepmc +1 more source
Morphologic Changes of Macular Choroidal Neovascularization on OCT Angiography Following Faricimab Therapy in Patients With AMD. [PDF]
Loya A +4 more
europepmc +1 more source
Massive Hemorrhage in PCV Is Associated With Lower-Than-Normal VEGF Level and Dramatically Elevated Inflammatory Cytokine Levels in Aqueous Mingxuan. [PDF]
Zhang M +5 more
europepmc +1 more source
Celafolin A-1 Ameliorates Subretinal Fibrosis via Inhibition of Crystallin Alpha B in a Laser-Induced Choroidal Neovascularization Mouse Model. [PDF]
Yu E +6 more
europepmc +1 more source
Association of Air Pollution Exposure with Incident Cataract Surgery and Neovascular Age-Related Macular Degeneration in 2 French Nationwide Cohorts. [PDF]
Gayraud L +11 more
europepmc +1 more source
Anti-VEGF Therapies in Retinal Disorders: Current Landscape and Future Directions. [PDF]
Sheth JU.
europepmc +1 more source

